Congressional Republicans are pursuing changes to the Affordable Care Act that would mean 10.7 million fewer Americans using its insurance marketplaces and Medicaid, a huge reduction that some view as a way to accomplish part of the health-care coverage cancellation that failed in 2017. They’re not branding it a repeal of President Barack Obama’s signature ...
Speaker Mike Johnson (R-La.) doubled down on his claim that there won’t be Medicaid cuts in President Trump’s “big, beautiful bill,” despite projections that millions of low-income individuals would lose health insurance as a result of the bill. Johnson, during an appearance on NBC’s “Meet the Press,” pushed back on independent projections that the bill would lead to 4.8 ...
Sutter Health, a 24-hospital health system based in Sacramento, Calif., is investing $23 million to expand primary and behavioral health care across Del Norte and Lake counties. In a June 2 news release, the health system said the investments aim to expand access and close critical care gaps for patients in rural communities. Six things to know, ...
Member support, including communications and convenience, is becoming more important than ever as the performance gap among health plans widens. “Brand performance gaps in the commercial health insurance market are no longer subtle — they’re widening in ways that directly affect satisfaction, retention and competitive strength,” said Caitlin Moling, senior director of global health care ...
Healthcare C-suite leaders are trying to keep pace with rapid changes in U.S. economic and regulatory policies in the first four months of the second Trump administration. Among 700 business executives across six industries, nearly half (48%) of business executives rank economic policy among the top three factors driving strategic change over the next one ...
Wegovy and other GLP-1 obesity and blood sugar control drugs accounted for 17% of pharmacy benefits spending at CBIZ employer clients with self-funded health plans in 2024, up from 13% in 2023, according to a new health care report. The broker’s clients spent spent $125 million on GLP-1 agonist drugs. That’s up from $81 million in ...